Literature DB >> 12837563

Zinc movement in the brain under kainate-induced seizures.

Atsushi Takeda1, Maki Hirate, Haruna Tamano, Naoto Oku.   

Abstract

On the basis of the evidence that elimination of 65Zn from the brain of epilepsy (EL) mice is facilitated by induction of seizures, zinc movement in the brain was studied in mice injected with kainate (12 mg/kg x 3), which exhibited status epilepticus within 120 min after the last injection of kainate. Zinc concentrations in the brain were determined 24 h after the last injection of kainate. Zinc concentrations in the hippocampus, amygdala and cerebral cortex, in which zinc-containing glutamatergic neuron terminals exist, were significantly decreased by the treatment with kainate, while that in the cerebellum was not decreased. Timm's stain in the brain was extensively attenuated 24 h after the last injection of kainate. These results indicate that zinc homeostasis in the brain is affected by kainate-induced seizures. In the hippocampus of rats injected with kainate (10 mg/kg), furthermore, the release of zinc and glutamate into the extracellular fluid was studied using in vivo microdialysis. The levels of zinc and glutamate in the perfusate were increased along with seizure severity after injection of kainate. It is likely that zinc concentration in the synaptic vesicles is decreased by the excess excitation of glutamatergic neurons. The present study suggests that the excessive release of zinc and glutamate from the neuron terminals under kainate-induced seizures is associated with the loss of zinc from the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837563     DOI: 10.1016/s0920-1211(03)00063-9

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

Review 1.  Trace metals in the brain: allosteric modulators of ligand-gated receptor channels, the case of ATP-gated P2X receptors.

Authors:  J Pablo Huidobro-Toro; Ramón A Lorca; Claudio Coddou
Journal:  Eur Biophys J       Date:  2007-10-31       Impact factor: 1.733

Review 2.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Homeostatic regulation of KCC2 activity by the zinc receptor mZnR/GPR39 during seizures.

Authors:  David Gilad; Sharon Shorer; Maya Ketzef; Alon Friedman; Israel Sekler; Elias Aizenman; Michal Hershfinkel
Journal:  Neurobiol Dis       Date:  2015-01-03       Impact factor: 5.996

Review 4.  Zinc signaling in the hippocampus and its relation to pathogenesis of depression.

Authors:  Atsushi Takeda
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

5.  Genetic and phenotypic analysis of seizure susceptibility in PL/J mice.

Authors:  Toshimori Kitami; Sheila Ernest; Laura Gallaugher; Lee Friedman; Wayne N Frankel; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2004-09       Impact factor: 2.957

6.  Structural optimization of Zn(II)-activated magnetic resonance imaging probes.

Authors:  Lauren M Matosziuk; Jonathan H Leibowitz; Marie C Heffern; Keith W MacRenaris; Mark A Ratner; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-06-18       Impact factor: 5.165

7.  Enhanced susceptibility to spontaneous seizures of noda epileptic rats by loss of synaptic zn(2+).

Authors:  Atsushi Takeda; Masashi Iida; Masaki Ando; Masatoshi Nakamura; Haruna Tamano; Naoto Oku
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

8.  Review: Cav2.3 R-type Voltage-Gated Ca2+ Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity.

Authors:  Carola Wormuth; Andreas Lundt; Christina Henseler; Ralf Müller; Karl Broich; Anna Papazoglou; Marco Weiergräber
Journal:  Open Neurol J       Date:  2016-09-30

9.  PTPRM Is Critical for Synapse Formation Regulated by Zinc Ion.

Authors:  Xiaoqiang Mo; Mengxue Liu; Jihong Gong; Ying Mei; Huidan Chen; Huajun Mo; Xiaofei Yang; Jun Li
Journal:  Front Mol Neurosci       Date:  2022-03-21       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.